Regulation of macrophage inhibitory factor (MIF) by epidermal growth factor receptor (EGFR) in the MCF10AT model of breast cancer progression

Journal of Proteome Research

Volumn 8, Issue 8, 2009, Pages 4062-4076

  Lim, Simin ^a   Choong, Lee Yee ^a   Chong, Poh Kuan ^a   Yunhao, Chen ^a   Lim, Yoon Pin ^a,b,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c BIOINFORMATICS INSTITUTE   (Singapore)

Author keywords

2D DIGE; Breast cancer; EGF; iTRAQ; MIF; Proteomics

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MACROPHAGE MIGRATION INHIBITION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE;

AMINO ACID SEQUENCE; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE; UPREGULATION; UTERINE CERVIX CANCER;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BREAST NEOPLASMS; CELL LINE; CELL LINE, TUMOR; DISEASE PROGRESSION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MAP KINASE KINASE 1; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY;

EID: 68549133577     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr900430n     Document Type: Article

References (45)

1. Jemal, A.; Siegel, R.; Ward, E.; Murray, T.; Xu, J.; Thun, M. J. Cancer Statistics, 2007. CA Cancer J. Clin. 2007, 57 (1), 43-66.
2. Lo, H. W.; Hsu, S. C.; Hung, M. C. EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization. Breast Cancer Res. Treat. 2006, 95 (3), 211-8.
3. Lynch, T. J.; Bell, D. W.; Sordella, R.; Gurubhagavatula, S.; Okimoto, R. A.; Brannigan, B. W.; Harris, P. L.; Haserlat, S. M.; Supko, J. G.; Haluska, F. G.; Louis, D. N.; Christiani, D. C.; Settleman, J.; Haber, D. A. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N. Engl. J. Med. 2004, 350 (21), 2129-39.
4. Paez, J. G.; Janne, P. A.; Lee, J. C.; Tracy, S.; Greulich, H.; Gabriel, S.; Herman, P.; Kaye, F. J.; Lindeman, N.; Boggon, T. J.; Naoki, K.; Sasaki, H.; Fujii, Y.; Eck, M. J.; Sellers, W. R.; Johnson, B. E.; Meyerson, M. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004, 304 (5676), 1497-500.
5. Bhargava, R.; Gerald, W. L.; Li, A. R.; Pan, Q.; Lal, P.; Ladanyi, M.; Chen, B. EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations. Mod. Pathol. 2005, 18 (8), 1027-33.
6. Generali, D.; Leek, R.; Fox, S. B.; Moore, J. W.; Taylor, C.; Chambers, P.; Harris, A. L. EGFR mutations in exons 18-21 in sporadic breast cancer. Ann. Oncol. 2007, 18 (1), 203-5.
7. O'Donovan, N.; Crown, J. EGFR and HER-2 antagonists in breast cancer. Anticancer Res. 2007, 27 (3A), 1285-94.
8. Kang, Y.; Siegel, P. M.; Shu, W.; Drobnjak, M.; Kakonen, S. M.; Cordon-Cardo, C.; Guise, T. A.; Massague, J. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003, 3 (6), 537-49.
9. Santner, S. J.; Dawson, P. J.; Tait, L.; Soule, H. D.; Eliason, J.; Mohamed, A. N.; Wolman, S. R.; Heppner, G. H.; Miller, F. R. Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res. Treat. 2001, 65 (2), 101-10.
10. Strickland, L. B.; Dawson, P. J.; Santner, S. J.; Miller, F. R. Progression of premalignant MCF10AT generates heterogeneous malignant variants with characteristic histologic types and immunohistochemical markers. Breast Cancer Res. Treat. 2000, 64 (3), 235-40.
11. Heppner, G. H.; Miller, F. R.; Shekhar, P. M. Nontransgenic models of breast cancer. Breast Cancer Res. 2000, 2 (5), 331-4.
12. Miller, F. R. Xenograft models of premalignant breast disease. J. Mammary Gland Biol. Neoplasia 2000, 5 (4), 379-91.
13. Chong, B. E.; Hamler, R. L.; Lubman, D. M.; Ethier, S. P.; Rosenspire, A. J.; Miller, F. R. Differential screening and mass mapping of proteins from premalignant and cancer cell lines using nonporous reversed-phase HPLC coupled with mass spectrometric analysis. Anal. Chem. 2001, 73 (6), 1219-27.
14. Chong, B. E.; Lubman, D. M.; Miller, F. R.; Rosenspire, A. J. Rapid screening of protein profiles of human breast cancer cell lines using non-porous reversed-phase high performance liquid chromatography separation with matrix-assisted laser desorption/ionization time-of-flight mass spectral analysis. Rapid Commun. Mass Spectrom. 1999, 13 (18), 1808-12.
15. Chong, B. E.; Lubman, D. M.; Rosenspire, A.; Miller, F. Protein profiles and identification of high performance liquid chromatography isolated proteins of cancer cell lines using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 1998, 12 (24), 1986-93.
16. Starcevic, S. L.; Diotte, N. M.; Zukowski, K. L.; Cameron, M. J.; Novak, R. F. Oxidative DNA damage and repair in a cell lineage model of human proliferative breast disease (PBD). Toxicol. Sci. 2003, 75 (1), 74-81.
17. Starcevic, S. L.; Elferink, C.; Novak, R. F. Progressive resistance to apoptosis in a cell lineage model of human proliferative breast disease. J. Natl. Cancer Inst. 2001, 93 (10), 776-82.
18. Tang, B.; Vu, M.; Booker, T.; Santner, S. J.; Miller, F. R.; Anver, M. R.; Wakefield, L. M. TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J. Clin. Invest. 2003, 112 (7), 1116-24.
19. Worsham, M. J.; Pals, G.; Schouten, J. P.; Miller, F.; Tiwari, N.; van Spaendonk, R.; Wolman, S. R. High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model. Breast Cancer Res. Treat. 2006, 96 (2), 177-86.
20. Chen, Y.; Choong, L. Y.; Lin, Q.; Philp, R.; Wong, C. H.; Ang, B. K.; Tan, Y. L.; Loh, M. C.; Hew, C. L.; Shah, N.; Druker, B. J.; Chong, P. K.; Lim, Y. P. Differential Expression of Novel Tyrosine Kinase Substrates during Breast Cancer Development. Mol. Cell. Proteomics 2007, 6 (12), 2072-87.
21. Choong, L. Y.; Lim, S.; Loh, M. C.; Man, X.; Chen, Y.; Toy, W.; Pan, M.; Chen, C. S.; Poonepalli, A.; Hande, M. P.; Tan, P. H.; Salto-Tellez, M.; Wong, C. Y.; Shah, N.; Druker, B. J.; Lim, Y. P. Progressive loss of epidermal growth factor receptor in a subpopulation of breast cancers: implications in target-directed therapeutics. Mol. Cancer Ther. 2007, 6 (11), 2828-42.
22. Dittadi, R.; Donisi, P. M.; Brazzale, A.; Cappellozza, L.; Bruscagnin, G.; Gion, M. Epidermal growth factor receptor in breast cancer. Comparison with non malignant breast tissue. Br. J. Cancer 1993, 67 (1), 7-9.
23. Tsutsumi, Y.; Naber, S. P.; DeLellis, R. A.; Wolfe, H. J.; Marks, P. J.; McKenzie, S. J.; Yin, S. neu oncogene protein and epidermal growth factor receptor are independently expressed in benign and malignant breast tissues. Hum. Pathol. 1990, 21 (7), 750-8.
24. Boeckmann, B.; Bairoch, A.; Apweiler, R.; Blatter, M. C.; Estreicher, A.; Gasteiger, E.; Martin, M. J.; Michoud, K.; O'Donovan, C.; Phan, I.; Pilbout, S.; Schneider, M. The SWISS-PROT protein knowledge-base and its supplement TrEMBL in 2003. Nucleic Acids Res. 2003, 31 (1), 365-70.
25. Shilov, I. V.; Seymour, S. L.; Patel, A. A.; Loboda, A.; Tang, W. H.; Keating, S. P.; Hunter, C. L.; Nuwaysir, L. M.; Schaeffer, D. A. The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol. Cell. Proteomics 2007, 6 (9), 1638-55.
26. Elias, J. E.; Gygi, S. P. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 2007, 4 (3), 207-14.
27. Tonge, R.; Shaw, J.; Middleton, B.; Rowlinson, R.; Rayner, S.; Young, J.; Pognan, F.; Hawkins, E.; Currie, I.; Davison, M. Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 2001, 1 (3), 377-96.
28. Ross, P. L.; Huang, Y. N.; Marchese, J. N.; Williamson, B.; Parker, K.; Hattan, S.; Khainovski, N.; Pillai, S.; Dey, S.; Daniels, S.; Purkayastha, S.; Juhasz, P.; Martin, S.; Bartlet-Jones, M.; He, F.; Jacobson, A.; Pappin, D. J. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 2004, 3 (12), 1154-69.
29. Gan, C. S.; Chong, P. K.; Pham, T. K.; Wright, P. C. Technical, experimental, and biological variations in isobaric tags for relative and absolute quantitation (iTRAQ). J. Proteome Res. 2007, 6 (2), 821-7.
30. Wang, F.; Duan, R.; Chirgwin, J.; Safe, S. H. Transcriptional activation of cathepsin D gene expression by growth factors. J. Mol. Endocrinol. 2000, 24 (2), 193-202.
31. Gassmann, M. G.; Stanzel, A.; Werner, S. Growth factor-regulated expression of enzymes involved in nucleotide biosynthesis: a novel mechanism of growth factor action. Oncogene 1999, 18 (48), 6667-76.
32. Jeon, S. Y.; Baek, K. H.; Kim, Y. S.; Park, C. G.; Kwon, H. S.; Ko, S. H.; Song, K. H.; Yoo, S. J.; Son, H. S.; Cha, B. Y.; Lee, K. W.; Son, H. Y.; Kang, S. K.; Yoon, K. H. Differentially up-regulated genes in proliferating porcine neonatal pancreas cells caused by epidermal growth factor. J. Cell Biochem. 2004, 91 (2), 354-64.
33. Kasper, M.; Schnidar, H.; Neill, G. W.; Hanneder, M.; Klingler, S.; Blaas, L.; Schmid, C.; Hauser-Kronberger, C.; Regl, G.; Philpott, M. P.; Aberger, F. Selective modulation of Hedgehog/GLI target gene expression by epidermal growth factor signaling in human keratinocytes. Mol. Cell. Biol. 2006, 26 (16), 6283-98.
34. Mitchell, R. A.; Bucala, R. Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF). Semin. Cancer Biol. 2000, 10 (5), 359-66.
35. Lue, H.; Thiele, M.; Franz, J.; Dahl, E.; Speckgens, S.; Leng, L.; Fingerle-Rowson, G.; Bucala, R.; Luscher, B.; Bernhagen, J. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Oncogene 2007, 26 (35), 5046-59.
36. Bucala, R.; Donnelly, S. C. Macrophage migration inhibitory factor: a probable link between inflammation and cancer. Immunity 2007, 26 (3), 281-5.
37. Hagemann, T.; Robinson, S. C.; Thompson, R. G.; Charles, K.; Kulbe, H.; Balkwill, F. R. Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis. Mol. Cancer Ther. 2007, 6 (7), 1993-2002.
38. Hudson, J. D.; Shoaibi, M. A.; Maestro, R.; Carnero, A.; Hannon, G. J.; Beach, D. H. A proinflammatory cytokine inhibits p53 tumor suppressor activity. J. Exp. Med. 1999, 190 (10), 1375-82.
39. Legendre, H.; Decaestecker, C.; Nagy, N.; Hendlisz, A.; Schuring, M. P.; Salmon, I.; Gabius, H. J.; Pector, J. C.; Kiss, R. Prognostic values of galectin-3 and the macrophage migration inhibitory factor (MIF) in human colorectal cancers. Mod. Pathol. 2003, 16 (5), 491-504.
40. Bando, H.; Matsumoto, G.; Bando, M.; Muta, M.; Ogawa, T.; Funata, N.; Nishihira, J.; Koike, M.; Toi, M. Expression of macrophage migration inhibitory factor in human breast cancer: association with nodal spread. Jpn. J. Cancer Res. 2002, 93 (4), 389-96.
41. Tomiyasu, M.; Yoshino, I.; Suemitsu, R.; Okamoto, T.; Sugimachi, K. Quantification of macrophage migration inhibitory factor mRNA expression in non-small cell lung cancer tissues and its clinical significance. Clin. Cancer Res. 2002, 8 (12), 3755-60.
42. Agarwal, R.; Whang, D. H.; Alvero, A. B.; Visintin, I.; Lai, Y.; Segal, E. A.; Schwartz, P.; Ward, D.; Rutherford, T.; Mor, G. Macrophage migration inhibitory factor expression in ovarian cancer. Am. J. Obstet. Gynecol. 2007, 196 (4), 1-5, 348.
43. Meyer-Siegler, K. L.; Iczkowski, K. A.; Leng, L.; Bucala, R.; Vera, P. L. Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells. J. Immunol. 2006, 177 (12), 8730-9.
44. Ren, Y.; Chan, H. M.; Fan, J.; Xie, Y.; Chen, Y. X.; Li, W.; Jiang, G. P.; Liu, Q.; Meinhardt, A.; Tam, P. K. Inhibition of tumor growth and metastasis in vitro and in vivo by targeting macrophage migration inhibitory factor in human neuroblastoma. Oncogene 2006, 25 (25), 3501-8.
45. Beswick, E. J.; Reyes, V. E. Macrophage migration inhibitory factor and interleukin-8 produced by gastric epithelial cells during Helicobacter pylori exposure induce expression and activation of the epidermal growth factor receptor. Infect. Immun. 2008, 76 (7), 3233-40.